| Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis. | |
| | |
MedLine Citation:
|
PMID: 17414871 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A 34-year-old woman in whom multiple sclerosis (MS) had been diagnosed 2 years earlier developed progressive bilateral visual loss associated with peripapillary exudative retinal detachment and other features of Vogt-Koyanagi-Harada (VKH) syndrome. She was treated with corticosteroid pulses and interferon beta-1A with visual acuity improvement and resolution of the retinal detachment. This is the first reported case of VKH syndrome in a patient with MS. The combination of VKH syndrome and MS suggests a common autoimmune pathogenesis. |
| | |
Authors:
|
Javier A Montero; M Eugenia Sanchis; Marta Fernandez-Munoz |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society Volume: 27 ISSN: 1070-8022 ISO Abbreviation: J Neuroophthalmol Publication Date: 2007 Mar |
Date Detail:
|
Created Date: 2007-04-06 Completed Date: 2007-05-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9431308 Medline TA: J Neuroophthalmol Country: United States |
Other Details:
|
Languages: eng Pagination: 36-40 Citation Subset: IM |
Affiliation:
|
VISSUM, Instituto Oftalmológico de Alicante, Retina Unit, Alicante, Spain. msm02va@wanadoo.es |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adjuvants, Immunologic
/
administration & dosage,
therapeutic use Adult Diagnosis, Differential Disease Progression Drug Administration Routes Drug Therapy, Combination Female Fluorescein Angiography Fundus Oculi Glucocorticoids / administration & dosage, therapeutic use Humans Interferon-beta / administration & dosage, therapeutic use Magnetic Resonance Imaging Multiple Sclerosis / complications*, diagnosis Tomography, Optical Coherence Uveomeningoencephalitic Syndrome / diagnosis, drug therapy, etiology* Visual Acuity |
| Chemical | |
Reg. No./Substance:
|
0/Adjuvants, Immunologic; 0/Glucocorticoids; 145258-61-3/interferon beta 1a; 77238-31-4/Interferon-beta |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Modified Lundie loops improve apraxia of eyelid opening.
Next Document: Mitochondrial ophthalmoplegia with fatigable weakness and elevated acetylcholine receptor antibody.